Hidenori Kitai

Epithelial-to-Mesenchymal Transition Defines Feedback Activation of Receptor Tyrosine Kinase Signaling Induced by MEK Inhibition in <i>KRAS</i> -Mutant Lung Cancer

Hidenori Kitai, Hiromichi Ebi, Shuta Tomida et al. · Cancer Discovery · 2016 · 154 citations · Full text

WEE1 inhibition enhances the antitumor immune response to PD-L1 blockade by the concomitant activation of STING and STAT1 pathways in SCLC

Hirokazu Taniguchi, Rebecca Caeser, Shweta S. Chavan et al. · Cell Reports · 2022 · 123 citations · Full text

Epithelial-to-Mesenchymal Transition Antagonizes Response to Targeted Therapies in Lung Cancer by Suppressing BIM

Kyung-A Song, Matthew J. Niederst, Timothy L. Lochmann et al. · Clinical Cancer Research · 2017 · 93 citations · Full text

Co-active receptor tyrosine kinases mitigate the effect of FGFR inhibitors in FGFR1-amplified lung cancers with low FGFR1 protein expression

Hiroshi Kotani, Hiromichi Ebi, Hidenori Kitai et al. · Oncogene · 2015 · 37 citations · Full text

Fgfr Inhibitors, Medicine, Receptor Tyrosine Kinase +8

Distinct dependencies on receptor tyrosine kinases in the regulation of MAPK signaling between BRAF V600E and non-V600E mutant lung cancers

Hiroshi Kotani, Yuta Adachi, Hidenori Kitai et al. · Oncogene · 2018 · 31 citations

Signal Transduction, Distinct Dependencies, Signaling Pathway +10